Roundtable Discussion: Precision Manufacturing in Allogeneic Cell Therapy by Overcoming Donor Variability, Gene Editing & Scale-Up Challenges
Time: 12:15 pm
day: Roundtable Discussion Track B
Details:
- Standardizing Donor Material: Tackling donor-to-donor variability and setting clear criteria for starting material quality
- Optimizing Gene Editing Strategies: Managing complex edits for immune evasion, persistence, and maintaining product consistency across multiple modifications
- Scaling Up Production and Fill-Finish: Addressing challenges in bioreactor selection, large-scale expansion, and efficient fill-finish solutions for high-volume therapies
